Anti-inflammatory effect of naringin and sericin combination on human peripheral blood mononuclear cells (hPBMCs) from patient with psoriasis

[1]  Weiliang Shi,et al.  Bombyx mori silk-based materials with implication in skin repair: Sericin versus regenerated silk fibroin , 2019, Journal of biomaterials applications.

[2]  N. Ismail,et al.  Preventive Effect of Naringin on Metabolic Syndrome and Its Mechanism of Action: A Systematic Review , 2019, Evidence-based complementary and alternative medicine : eCAM.

[3]  L. Ribeiro,et al.  Silkworm Sericin: Properties and Biomedical Applications , 2016, BioMed research international.

[4]  J. Alam,et al.  Wound healing potential of naringin ointment formulation via regulating the expression of inflammatory, apoptotic and growth mediators in experimental rats , 2016, Pharmaceutical biology.

[5]  F. Nestle,et al.  Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine. , 2015, Clinical and experimental rheumatology.

[6]  Shan Jiang,et al.  Biomarkers of An Autoimmune Skin Disease—Psoriasis , 2015, Genom. Proteom. Bioinform..

[7]  J. McElwee,et al.  IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases , 2015, Nature Medicine.

[8]  L. Skov,et al.  Targeting of interleukin-17 in the treatment of psoriasis , 2014, Clinical, Cosmetic and Investigational Dermatology.

[9]  Sarah L. Gaffen,et al.  The IL-23–IL-17 immune axis: from mechanisms to therapeutic testing , 2014, Nature Reviews Immunology.

[10]  M. Marazzi,et al.  TNF-α Blocker Effect of Naringenin-Loaded Sericin Microparticles that Are Potentially Useful in the Treatment of Psoriasis , 2014, International journal of molecular sciences.

[11]  S. Sarker,et al.  Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action. , 2014, Advances in nutrition.

[12]  Mayte Suárez-Fariñas,et al.  Immunology of psoriasis. , 2014, Annual review of immunology.

[13]  Jinhong Hu,et al.  Curcumin Inhibits Imiquimod-Induced Psoriasis-Like Inflammation by Inhibiting IL-1beta and IL-6 Production in Mice , 2013, PloS one.

[14]  David A. Martin,et al.  The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses. , 2013, Trends in immunology.

[15]  Rosa Parisi,et al.  Global epidemiology of psoriasis: a systematic review of incidence and prevalence. , 2013, The Journal of investigative dermatology.

[16]  Masahiro Tanaka,et al.  Extraction of Citrus Flavonoids from Peel of Citrus Junos Using Supercritical Carbon Dioxide with Polar Solvent , 2013 .

[17]  Y. Liu,et al.  Naringin inhibits chemokine production in an LPS-induced RAW 264.7 macrophage cell line. , 2012, Molecular medicine reports.

[18]  J. Gommerman,et al.  Fine-tuning of dendritic cell biology by the TNF superfamily , 2012, Nature Reviews Immunology.

[19]  V. Jala,et al.  Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation. , 2011, Immunity.

[20]  T. Tencomnao,et al.  Effects of Thai Medicinal Herb Extracts with Anti-Psoriatic Activity on the Expression on NF-κB Signaling Biomarkers in HaCaT Keratinocytes , 2011, Molecules.

[21]  Lisa C. Zaba,et al.  A subpopulation of CD163-positive macrophages is classically activated in psoriasis. , 2010, The Journal of investigative dermatology.

[22]  N. J. Eungdamrong,et al.  Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasis. , 2010, The Journal of allergy and clinical immunology.

[23]  S. Wanichwecharungruang,et al.  An efficient method for the large scale isolation of naringin from pomelo (Citrus grandis) peel , 2009 .

[24]  Frank O. Nestle,et al.  Mechanisms of Disease: Psoriasis. , 2009 .

[25]  O. Unsalan,et al.  FT‐Raman and FT‐IR spectral and quantum chemical studies on some flavonoid derivatives: Baicalein and Naringenin , 2009 .

[26]  C. Parish,et al.  Use of the intracellular fluorescent dye CFSE to monitor lymphocyte migration and proliferation. , 2002, Current protocols in immunology.

[27]  N. J. Eungdamrong,et al.  Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. , 2009, The Journal of investigative dermatology.

[28]  Daisuke Tsuruta,et al.  NF-kappaB links keratinocytes and lymphocytes in the pathogenesis of psoriasis. , 2009, Recent patents on inflammation & allergy drug discovery.

[29]  P. Spuls,et al.  Topical treatments in psoriasis: today and tomorrow. , 2008, Clinics in dermatology.

[30]  M. Traub,et al.  Psoriasis--pathophysiology, conventional, and alternative approaches to treatment. , 2007, Alternative medicine review : a journal of clinical therapeutic.

[31]  I. Mellman,et al.  Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide , 2007, Nature.

[32]  E. Bixler,et al.  IL-6 and Its Circadian Secretion in Humans , 2005, Neuroimmunomodulation.

[33]  N. Shear,et al.  Psoriasis and the new biologic agents: interrupting a T-AP dance , 2004, Canadian Medical Association Journal.

[34]  M. Dhodapkar,et al.  Increased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis Vulgaris , 2004, The Journal of experimental medicine.

[35]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[36]  D. L. Pavia,et al.  Introduction to spectroscopy : a guide for students of organic chemistry , 1996 .

[37]  J. Augustin,et al.  Precolumn phenylisothiocyanate derivatization and liquid chromatography of amino acids in food. , 1989, Journal - Association of Official Analytical Chemists.